Lam Research Corporation December quarter 2021 financial results January 26, 2022 -- 1 of 25 -- L A M R E S E A R C H Cautionary statement regarding forward-looking statements This presentation and the accompanying discussion contain “forward-looking statements” under U.S. securities laws. Forward-looking statements include any statements that are not statements of historical fact. Examples of forward-looking statements include, but are not limited to: (1) anticipated business, balance sheet, cash flow and financial measures and results, including guidance, whether on a GAAP or non-GAAP basis; (2) economic, market, industry and industry segment expectations; (3) product performance and changes in market share or customer demands; (4) our ability to successfully execute business, capital allocation, product and growth plans or strategies, or otherwise deliver value for customers and stockholders; (5) the impact and expected duration of supply chain disruptions, and our ability to mitigate them; (6) the impact of the COVID-19 pandemic on our operations and financial results, and our ability to mitigate operational and business impacts caused by it; and (7) the impact of trade regulations, export controls and trade disputes. Forward-looking statements speak only as of the date they are made and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed, including: supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; trade regulations, export controls, trade disputes and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other factors discussed in our filings with the Securities and Exchange Commission (“SEC”), including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 27, 2021 and our quarterly report on Form 10-Q for the quarter ended September 26, 2021. You should not place undue reliance on forward- looking statements. Lam undertakes no obligation to update any forward-looking statements. -- 2 of 25 -- L A M R E S E A R C H Business review & industry outlook Tim Archer President and Chief Executive Officer -- 3 of 25 -- L A M R E S E A R C H Revenue records in all market segments and every sub- segment of CSBG Market share gains in etch and deposition December quarter results impacted by unexpected supply chain delays Delivered record revenue and EPS in calendar year 2021 EPS = earnings per share EPS calculated on a non-GAAP basis. Reconciliations of U.S GAAP results to non-GAAP results can be found at the end of this presentation CSBG = Customer Support Business Group -- 4 of 25 -- L A M R E S E A R C H Continued growth in WFE spending Calendar year 2021 WFE of mid-$80 billion consistent with prior commentary Growth from powerful end-demand, rising device complexity, strong semiconductor industry profitability, and regional government support Technology landscape continues to build with drivers such as AI, IoT, Cloud, 5G and the upcoming metaverse Calendar year 2022 spending expected in $100 billion range, with strong growth across all market segments WFE = wafer fabrication equipment -- 5 of 25 -- L A M R E S E A R C H CSBG continues to exceed expectations ~44,000 ~50,000 ~56,000 ~61,000 ~66,000 ~75,000 2016 2017 2018 2019 2020 2021 GROWING INSTALLED BASE UNITS Large and growing installed base key to our product innovation process Calendar year 2021 ending chamber count of ~75,000 units, up ~13% year-over-year Revenue per chamber grew nearly twice the growth of chamber count, at ~24% year-over-year Expect calendar year 2022 to be another strong growth year for CSBG -- 6 of 25 -- L A M R E S E A R C H 2021 was a year of significant milestones Vantex ™ • Fastest new etch product ramp in Lam history and set to double revenue for this product in 2022 Vector ® DT • Backside deposition PTOR at all 3D NAND customers for >200-layer devices Selective etch • Leading-edge wins with our selective etch, strip and surface treatment solutions, including for gate-all-around applications and first win in DRAM Critical bitline/spacer • Increased deposition market share with application wins for RC reduction and qualified at all leading nodes PTOR = production tool of record RC = resistance capacitance -- 7 of 25 -- L A M R E S E A R C H Preparing for another outstanding period of growth + Near term: Alleviate supply constraints + Product momentum + Installed-base outperformance + Tremendous WFE demand Great position for calendar year 2022 -- 8 of 25 -- L A M R E S E A R C H December quarter 2021 financial results & March quarter 2022 outlook Doug Bettinger Executive Vice President and Chief Financial Officer -- 9 of 25 -- L A M R E S E A R C H CY 2021 REVENUE CY 2021 EARNINGS PER SHARE* $16.5B CY 2020 revenue: $11.9B $32.46 CY 2020 EPS*: $20.45 Calendar year highlights *Data are presented on a non-GAAP basis. Reconciliations of U.S. GAAP results to non-GAAP results can be found at the end of this presentation. -- 10 of 25 -- L A M R E S E A R C H Q DEC'21 REVENUE Q DEC'21 DEFERRED REVENUE $4.23B Q Sep'21 revenue: $4.30B $1.46B Q Sep'21 deferred revenue: $1.11B December quarter highlights -- 11 of 25 -- L A M R E S E A R C H December quarter revenue mix System revenue segments* Revenue by region NVM = non-volatile memory *Systems revenue includes equipment and equipment upgrade sales from etch, deposition, clean, and our Reliant® product line Record level of logic/other revenue dollars Memory 58% -- 12 of 25 -- L A M R E S E A R C H Q DEC’21 CSBG REVENUE $1.49B Q Sep'21 CSBG revenue: $1.38B Q Dec'20 CSBG revenue: $1.15B Customer Support Business Group 12th consecutive record Reliant® quarter -- 13 of 25 -- L A M R E S E A R C H Q DEC'21 Q SEP'21 Revenue $4,227M $4,304M Non-GAAP Gross Margin* 46.8% 46.0% Non-GAAP Operating Expenses* $627M $586M Non-GAAP Operating Income* $1,352M $1,393M Non-GAAP Operating Income as a percentage of Revenue* 32.0% 32.4% Non-GAAP Other Income (Expense), Net* $19M $(36)M U.S. GAAP Diluted EPS $8.44 $8.27 Non-GAAP Diluted EPS* $8.53 $8.36 Diluted Share Count 142M 143M December quarter financial results *A reconciliation of U.S. GAAP results to non-GAAP results can be found at the end of this presentation. -- 14 of 25 -- L A M R E S E A R C H Key balance sheet and financial metrics Q DEC'21 Q SEP'21 Total Consolidated Gross Cash Balance $5,580M $4,863M Account Receivables, Net $3,403M $3,397M DSO 73 Days 72 Days Inventories $3,074M $2,872M Inventory Turns 2.9 3.2 Deferred Revenue* $1,458M $1,110M Capital Expenditures $138M $136M Equity Compensation Expense $63M $58M Amortization Expense $20M $19M Depreciation Expense $62M $61M Share Repurchases $430M $1,210M Cash Dividends $211M $185M Headcount ~16,300 ~15,400 *Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Estimated future revenue from shipments to customers in Japan was approximately $328M as of December 26, 2021 and $331M as of September 26, 2021. -- 15 of 25 -- L A M R E S E A R C H March 2022 quarter guidance $4.25B +/- $300M Revenue 45.0% +/- 1% Non-GAAP gross margin 29.5% +/- 1% Non-GAAP operating margin $7.45 +/- $0.75 Non-GAAP earnings per share* A reconciliation of U.S. GAAP projected results to non-GAAP projected results can be found at the end of this presentation *Based on a diluted share count of approximately 141 Million shares -- 16 of 25 -- L A M R E S E A R C H Q&A -- 17 of 25 -- L A M R E S E A R C H Appendix – reconciliation Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income (in thousands, except per share data) (unaudited) Three Months Ended December 26, 2021 September 26, 2021 U.S. GAAP net income $ 1,194,830 $ 1,179,744 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 1,092 1,092 Elective deferred compensation ("EDC") related liability valuation (decrease) increase - cost of goods sold (8) 1,896 EDC related liability valuation (decrease) increase - research and development (15) 3,412 Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 12,357 12,357 EDC related liability valuation (decrease) increase - selling, general and administrative (10) 2,275 Amortization of note discounts - other income (expense), net 689 683 Loss (Gain) on EDC related asset - other income (expense), net 56 (7,437) Net income tax benefit on non-GAAP items (1,651) (2,461) Non-GAAP net income $ 1,207,340 $ 1,191,561 Non-GAAP net income per diluted share $ 8.53 $ 8.36 U.S. GAAP net income per diluted share $ 8.44 $ 8.27 U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 141,530 142,612 -- 18 of 25 -- L A M R E S E A R C H Twelve Months Ended December 26, 2021 December 27, 2020 U.S. GAAP net income $ 4,590,352 $ 2,964,134 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 4,368 5,794 Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 8,130 7,040 Product rationalization - cost of goods sold 5,774 — EDC related liability valuation increase - research and development 14,633 12,672 Product rationalization - research and development 426 — Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 49,428 49,428 EDC related liability valuation increase - selling, general and administrative 9,772 8,448 Amortization of note discounts - other income (expense), net 3,293 3,900 Gain on EDC related asset - other income (expense), net (32,085) (29,441) Net income tax benefit on non-GAAP items (10,447) (10,786) Income tax benefit on the conclusion of certain tax matters — (276) Cumulative income tax benefit reversal due to a court ruling — (821) Non-GAAP net income $ 4,643,644 $ 3,010,092 Non-GAAP net income per diluted share $ 32.46 $ 20.45 U.S. GAAP net income per diluted share $ 32.09 $ 20.14 U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 143,066 147,185 U.S. GAAP and non-GAAP revenue $ 16,523,902 $ 11,928,806 Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income (in thousands, except per share data) (unaudited) Appendix – reconciliation -- 19 of 25 -- L A M R E S E A R C H Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income (in thousands, except percentages) (unaudited) Three Months Ended December 26, 2021 September 26, 2021 U.S. GAAP gross margin $ 1,977,916 $ 1,976,754 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations 1,092 1,092 EDC related liability valuation (decrease) increase (8) 1,896 Non-GAAP gross margin $ 1,979,000 $ 1,979,742 U.S. GAAP gross margin as a percentage of revenue 46.8 % 45.9 % Non-GAAP gross margin as a percentage of revenue 46.8 % 46.0 % U.S. GAAP operating expenses $ 639,777 $ 604,521 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations (12,357) (12,357) EDC related liability valuation decrease (increase) 25 (5,687) Non-GAAP operating expenses $ 627,445 $ 586,477 U.S. GAAP operating income $ 1,338,139 $ 1,372,233 Non-GAAP operating income $ 1,351,555 $ 1,393,265 U.S. GAAP operating income as percent of revenue 31.7 % 31.9 % Non-GAAP operating income as a percent of revenue 32.0 % 32.4 % Appendix – reconciliation -- 20 of 25 -- L A M R E S E A R C H Reconciliation of U.S. GAAP Other Income (Expense), Net to Non-GAAP Other Income (Expense), Net (in thousands) (unaudited) Three Months Ended December 26, 2021 September 26, 2021 U.S. GAAP Other income (expense), net $ 17,999 $ (28,857) Pre-tax non-GAAP items: Amortization of note discounts 689 683 Loss (gain) on EDC related asset 56 (7,437) Non-GAAP Other income (expense), net $ 18,744 $ (35,611) Appendix – reconciliation -- 21 of 25 -- L A M R E S E A R C H Calculation of Free Cash Flows (in thousands) (unaudited) Three Months Ended Twelve Months Ended March 28, 2021 June 27, 2021 September 26, 2021 December 26, 2021 December 26, 2021 U.S. GAAP net cash provided by operating activities $ 1,165,080 $ 1,435,935 $ 457,524 $ 1,440,506 $ 4,499,045 U.S. GAAP cash used for capital expenditures and intangible assets (89,596) (104,622) (136,427) (138,493) (469,138) Total free cash flow $ 1,075,484 $ 1,331,313 $ 321,097 $ 1,302,013 $ 4,029,907 Appendix – reconciliation -- 22 of 25 -- L A M R E S E A R C H Reconciliation of U.S. GAAP Income Tax Rate to Non-GAAP Income Tax Rate (in thousands, except percentages) (unaudited) Three Months Ended December 26, 2021 September 26, 2021 U.S. GAAP income before income taxes $ 1,356,138 $ 1,343,376 U.S. GAAP income tax expense $ 161,308 $ 163,632 U.S. GAAP income tax rate 11.9 % 12.2 % Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations - cost of goods sold $ 1,092 $ 1,092 Elective deferred compensation ("EDC") related liability valuation (decrease) increase - cost of goods sold (8) 1,896 EDC related liability valuation (decrease) increase - research and development (15) 3,412 Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 12,357 12,357 EDC related liability valuation (decrease) increase - selling, general and administrative (10) 2,275 Amortization of note discounts - other income (expense), net 689 683 Loss (Gain) on EDC related asset - other income (expense), net 56 (7,437) Non-GAAP income before taxes $ 1,370,299 $ 1,357,654 Net income tax benefit on non-GAAP items $ 1,651 $ 2,461 Non-GAAP income tax expense $ 162,959 $ 166,093 Non-GAAP income tax rate 11.9 % 12.2 % Appendix – reconciliation -- 23 of 25 -- L A M R E S E A R C H Reconciliation of U.S. GAAP to Non-GAAP Guidance for the quarter ended March 27, 2022 The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or recognized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows: • Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $1 million. • Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $13 million. • Net income per diluted share - amortization related to intangible assets acquired though business combinations, $13 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($2 million); totaling $12 million. U.S. GAAP Reconciling Items Non-GAAP Revenue $4.25 Billion +/- $300 Million — $4.25 Billion +/- $300 Million Gross margin as a percentage of revenue 45.0% +/- 1% $ 1 Million 45.0% +/- 1% Operating income as a percentage of revenue 29.2% +/- 1% $ 13 Million 29.5% +/- 1% Net income per diluted share $7.36 +/- $0.75 $ 12 Million $7.45 +/- $0.75 Diluted share count 141 Million — 141 Million Appendix – reconciliation -- 24 of 25 -- -- 25 of 25 --